Why the study?
Does intravenous adenosine triphosphate improve termination of paroxysmal supraventricular tachycardia in patients with paroxysmal supraventricular tachycardia?
Does intravenous adenosine triphosphate improve termination of paroxysmal supraventricular tachycardia in patients with paroxysmal supraventricular tachycardia?
Intravenous adenosine triphosphate is a highly effective and rapidly acting agent for the termination of paroxysmal supraventricular tachycardia.
Answers are grounded in this paper and cite their sources.
May support adenosine triphosphate for PSVT termination; hypothesis-generating, requiring randomized confirmation.
Intravenous adenosine triphosphate rapidly terminated all 11 episodes of paroxysmal supraventricular tachycardia in 10 patients. Eight patients reported side effects but these resolved within 20 seconds and did not require treatment. Adenosine triphosphate is a suitable agent for the rapid termination of paroxysmal supraventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
Saito et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: